Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors is a research paper published in United European Gastroenterology Journal (2020). On theSindex it has a DataRank of 0. It has been cited 30 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: K23DK117055, T32DK062708
NIDDK NIH HHS
Grant: T32 DK062708
NIDDK NIH HHS
Grant: K23 DK117055
FWCI
1.37
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Determinants of and interventions for Proton Pump Inhibitor prescription behavior: A systematic scoping review
Additional file 1 of Determinants of and interventions for Proton Pump Inhibitor prescription behavior: A systematic scoping review
Additional file 4 of Determinants of and interventions for Proton Pump Inhibitor prescription behavior: A systematic scoping review
Additional file 4 of Determinants of and interventions for Proton Pump Inhibitor prescription behavior: A systematic scoping review
Additional file 2 of Determinants of and interventions for Proton Pump Inhibitor prescription behavior: A systematic scoping review
Additional file 3 of Determinants of and interventions for Proton Pump Inhibitor prescription behavior: A systematic scoping review
Additional file 2 of Determinants of and interventions for Proton Pump Inhibitor prescription behavior: A systematic scoping review
Additional file 3 of Determinants of and interventions for Proton Pump Inhibitor prescription behavior: A systematic scoping review